SLC7A11 and hepatocellular carcinoma: Consistently, SLC7A11‐WT, but not SLC7A11‐S26A, enhanced cystine uptake and GSH levels of HCC cells, while decreased lipid ROS levels and cell sensitivity to RSL3 treatment (Figure 7O–R; Figure S8E–H, Supporting Information).